Summary (150 words)
Introduction
generalized suppression of innate immune activation because it also reduced the activation of ( Figure 5D , E). As a negative control, infection of THP-1 with empty vector had no effect on IRF3
by Vpr was sensitive to Vpr mutation, with the same specificity as before (Compare Figure 3, 4, 
272
5F, S5G-J). Vpr F34I/P35N and Vpr Q65R failed to efficiently suppress IRF3 nuclear localization 
287
did not induce NF-κB-luc expression ( Figure 6A ). Viral doses were equalized by measurement of
288
RT activity (SGPERT) (Vermeire et al., 2012) . Vpr positive, and Vpr negative, HIV-1 GFP were 289 equally infectious and genome-free VLP were not infectious, as expected ( Figure 6B ). Vpr 290 expression in THP-1 using pCSVIG vector, but not empty vector expression, suppressed 291 subsequent cGAMP-mediated activation of the NF-κB-sensitive gene IL6 ( Figure 6C ). We could 292 not detect NF-κB nuclear localization in THP-1 after cGAMP treatment of THP-1, perhaps due to 293 timing, so we tested mutant Vpr specificity using poly I:C to stimulate NF-κB nuclear localization 294 in differentiated THP-1. We found that Vpr inhibited NF-κB nuclear localisation with similar 295 sensitivity to mutation as for IRF3. Activation of NF-κB nuclear translocation by poly I:C, 296 measured by immunofluorescence in the same way as IRF3 nuclear localization, was 297 suppressed by wild type Vpr and Vpr R80A but not by Vpr F34I/P35N or Vpr Q65R ( Figure 6D , 298 S6B).
300
Previous work has shown that Vpr inhibits the activity of the human CMV immediate early 301 (CMVie) promoter (X. Liu et al., 2015) . We hypothesized that this effect may be due to the as several other NF-κB sensitive constructs expressing luciferase ( Figure S6A ). Importantly, Vpr mutants F34I/P35N and Vpr Q65R suppressed GFP expression much less effectively that WT Vpr or Vpr R80A, concordant with this being due to inhibition of transcription factor nuclear entry construct in which GFP is driven from the Ubiquitin C (Ub) promoter (Matsuda & Cepko, 2004) or proteins, and prevents them from efficiently recruiting and transporting transcription factors IRF3
and NF-κB into the nucleus after innate immune activation. 
Discussion

376
It is noteworthy that the Vpr DCAF1 binding mutant Vpr Q65R was somewhat mislocalised 
404
despite depending on NF-ĸB activity for enhancement of viral transcription (Griffin et al., 1989) .
405
One possibility is that once Gag is expressed, Gag recruits Vpr to viral particles to prevent further 
408
Vpr has previously been shown to interact with KPNA1, 2 and 4 (Nitahara-Kasahara et al. Our data also likely explain previous reports of the suppression of expression from co-consistent with this model (Figure 6 ). It is likely that inhibition of NF-ĸB nuclear transport inhibits 424 expression from the NF-ĸB-dependent CMV promoter, but another possibility is that transcription 425 factor bound to cytoplasmic plasmid DNA has a role in importing DNA into the nucleus, and it is 426 plasmid transport that is inhibited (Mesika et al., 2001 ). Our model is summarized in Figure S7 . 
451
We and others, have argued that the genome of wild type HIV-1 is not efficiently sensed by 
475
In summary these findings highlight the crucial role of particle associated Vpr in inhibiting innate 476 immune activation during the early stages of the viral life cycle. We propose that the further study 
571
Cells were maintained at 37°C in 5% CO 2 in a humidified incubator for 72 h. CD4+ T cells were 
601
Expression of each gene was normalised to an internal control (GAPDH) and these values were 
666
Generation of Vpr mutants
667
Site directed mutagenesis was performed using Pfu Turbo DNA Polymerase (Agilent) according
668
to the manufacturer's instructions with the following primers using either pCDNA3.1 or pCSVIG 669 encoding SUMA Vpr as template.
Rev 5'-GATGAACAGCAGCTGCCGCAGGATTCTGATGATGGC-3'
674
VprR80A: Fwd 5'-GGCTGCCGGCACAGCGCCATCGGCATCACCCCT-3',
675
Rev 5'-AGGGGTGATGCCGATGGCGCTGTGCCGGCAGCC-3'
677
Co-immunoprecipitation assays
678
HEK293T cells were grown in 10 cm dishes and co-transfected with plasmids expressing a 
835
Blue lines represent mean translocation coefficient.
837
(E) Percentage of cells in Figure 5D with IRF3 translocation coefficient greater than 0.5 (above 
848
Data in B is expressed as means ± SEM (n = 2). Data is analysed using two-way ANOVA: *
849
(p<0.05), ** (p<0.01), *** (p<0.001), **** (p<0.0001) compared to empty vector or empty VLP. 
